Literature DB >> 16171988

Non-specific effects of leukotriene synthesis inhibitors on HeLa cell physiology.

Alan Sabirsh1, Jesper Bristulf, Ulf Karlsson, Christer Owman, Jesper Z Haeggström.   

Abstract

We examined the effects of various leukotriene synthesis inhibitors on calcium signalling in HeLa cells, before and after transfection with BLT(1). All of the inhibitors studied were found to reduce increases in intracellular calcium concentration induced by BLT(1), but also by an ionophore or activation of various G-protein coupled receptors, regardless of BLT(1) expression. In order to explore the mechanism of these apparently general effects we examined HeLa cell expression of leukotriene receptors and biosynthetic enzymes and found that the genes for key leukotriene synthesis enzymes and all of the leukotriene receptors were not expressed. Leukotrienes are involved in the pathology of a variety of cancers, and for HeLa cells leukotrienes have been reported to be important for aspects of the carcinogenic phenotype. We find that leukotriene synthesis inhibitors have non-specific effects, so careful controls are necessary to avoid interpreting non-specific effects as evidence for leukotriene involvement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16171988     DOI: 10.1016/j.plefa.2005.08.004

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  3 in total

1.  5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity.

Authors:  A S Fischer; J Metzner; S D Steinbrink; S Ulrich; C Angioni; G Geisslinger; D Steinhilber; T J Maier
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

2.  5-lipoxygenase: underappreciated role of a pro-inflammatory enzyme in tumorigenesis.

Authors:  Dieter Steinhilber; Astrid Stefanie Fischer; Julia Metzner; Svenja Dorothea Steinbrink; Jessica Roos; Martin Ruthardt; Thorsten Jürgen Maier
Journal:  Front Pharmacol       Date:  2010-12-24       Impact factor: 5.810

3.  Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective.

Authors:  Medi Kori; Kazim Yalcin Arga
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.